Adverse Reactions to Foods: What is the Gold Standard?

2001 ◽  
Vol 11 (2) ◽  
pp. 127-135
Author(s):  
Honor M. Anthony
Nutrients ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 2228
Author(s):  
Martin Hrubisko ◽  
Radoslav Danis ◽  
Martin Huorka ◽  
Martin Wawruch

The intake of food may be an initiator of adverse reactions. Food intolerance is an abnormal non-immunological response of the organism to the ingestion of food or its components in a dosage normally tolerated. Despite the fact that food intolerance is spread throughout the world, its diagnosing is still difficult. Histamine intolerance (HIT) is the term for that type of food intolerance which includes a set of undesirable reactions as a result of accumulated or ingested histamine. Manifestations may be caused by various pathophysiological mechanisms or a combination of them. The problem with a “diagnosis” of HIT is precisely the inconstancy and variety of the manifestations in the same individual following similar stimuli. The diagnosing of HIT therefore requires a complex time-demanding multidisciplinary approach, including the systematic elimination of disorders with a similar manifestation of symptoms. Among therapeutic approaches, the gold standard is a low-histamine diet. A good response to such a diet is considered to be confirmation of HIT. Alongside the dietary measures, DAO supplementation supporting the degradation of ingested histamine may be considered as subsidiary treatment for individuals with intestinal DAO deficiency. If antihistamines are indicated, the treatment should be conscious and time-limited, while 2nd or 3rd generation of H1 antihistamines should take precedence.


Author(s):  
Aglaciene Lopes da Silva ◽  
Camila Granado de Bastos ◽  
Flavia Caires Domingos ◽  
Michele Cristina da Rocha Pinto ◽  
Claudinei Alves Santana

Introduction: Schizophrenia is one of the most relevant mental disorders in public health, causing great distress for the patient and his/her family members. The persistence of symptoms characterizes refractoriness of the disease that is treated with clozapine considered the gold standard in treatment, but its adverse reactions can be as intense as the symptoms of the disorder. Objective: To develop a pharmacotherapeutic follow-up form for caregivers of adult patients with schizophrenia would refract from the use of clozapine. Methods: The search for the articles was carried out in the government databases and websites from November 15, 2018 to January 15, 2019, published from 2012. Result: Thirty-seven articles were found, excluding 20 articles, including in this review 17 articles, 2 books, 4 clinical protocols and 1 drug monograph. Conclusion: The proposal to develop the pharmacotherapeutic follow-up form is to identify adverse reactions that may influence the treatment of pharmacological treatment and reduce the unwanted effects of treatment as a consequence to improve the patient's quality of life.


2021 ◽  
Vol 9 ◽  
pp. 2050313X2110197
Author(s):  
Michelle Iris Jakobsen ◽  
H Grønborg ◽  
H V Hansen ◽  
A Fink-Jensen

Clozapine is gold standard for the management of treatment-resistant schizophrenia. It can offer life-changing symptom reduction where other antipsychotics have failed, and for these patients, treatment with clozapine should be maintained, if in any possible way. However, treatment with clozapine comes with a risk of developing potentially fatal adverse reactions, for example, severe neutropenia or agranulocytosis, in which case, treatment must be discontinued. Here, we present a case of clozapine-related neutropenia that commenced after the addition of sodium valproate. A subsequent re-challenge to clozapine resulted in severe neutropenia and led to the permanent cessation of clozapine treatment. The patient had been tolerating clozapine for more than a year before the addition of sodium valproate. The awareness of an interaction between clozapine and sodium valproate could help reduce the risk of clozapine-induced neutropenia and subsequent clozapine discontinuation.


2005 ◽  
Vol 173 (4S) ◽  
pp. 378-378
Author(s):  
Arthur C. Pinto
Keyword(s):  

2004 ◽  
Vol 171 (4S) ◽  
pp. 469-469 ◽  
Author(s):  
John S. Lam ◽  
Oleg Shvarts ◽  
Mehrdad Alemozaffarder ◽  
Hyung L. Kim ◽  
He-jing Wang ◽  
...  

2010 ◽  
Vol 44 (6) ◽  
pp. 10-11
Author(s):  
JENNIE SMITH
Keyword(s):  

2007 ◽  
Vol 40 (7) ◽  
pp. 18-19
Author(s):  
ELIZABETH MECHCATIE
Keyword(s):  

2005 ◽  
Vol 62 (2) ◽  
pp. 65-68 ◽  
Author(s):  
Holzinger ◽  
Klaiber

Die laparoskopische Cholezystektomie hat sich in weniger als zehn Jahren seit ihrer Einführung im Jahre 1986 zum Gold-Standard in der Behandlung des unkomplizierten und komplizierten Gallensteinleidens entwickelt. Aufgrund ihres durchschlagenden Erfolges ist sie zum Trendsetter der minimal-invasiven Chirurgie geworden, die auf allen Gebieten der Chirurgie die Behandlungsmethoden revolutioniert hat. Obwohl für uns heute selbstverständlich, blickt die minimal-invasive Chirurgie auf eine langwierige und hindernisreiche Entwicklungsgeschichte zurück. Ziel dieser Arbeit ist es, einen kurzen Überblick über die Geschichte der Laparoskopie und der laparoskopischen Cholezystektomie sowie deren Auswirkung auf die Entwicklung der minimal-invasiven Chirurgie zu geben.


Sign in / Sign up

Export Citation Format

Share Document